Semaglutide is a newly licensed injectable prescription medication used for obese (BMI ≥30) and overweight adults (BMI ≥27) with a weight related medical problem to help them lose weight. Semaglutide is 94% similar to natural human GLP-1 and therefore acts as a physiological regulator of appetite and thereby reducing food intake by reducing feelings of hunger and increasing feelings of fullness. For long-term success the treatment needs to be combined with lifestyle changes including diet and exercise. Weight loss can lead to secondary benefits by improving health problems such as cardiovascular risk factors including hypertension, blood glucose levels and waist circumference.
This is a Weight Loss Program using medications that have been approved individually by the FDA. The manufacturer's insert recommends these drugs for short-term use in the treatment of weight loss. However, it is important to note that sometimes the doses, drug combination and duration of treatments are "off label" which means that it is legal and perfectly acceptable for doctors to use these therapies according to their best judgement and medical experience. While potential exists for class IV drugs, a four-year study showed NO abuse or dependence. We treat overweight and obesity as chronic illnesses, which sometimes require multi-drug therapy and long-term maintenance. This is similar to treating high blood pressure, diabetes and other chronic conditions which are "controlled" but not "cured".
We offer a $400.00 monthly membership to help you on your weight loss journey.